Legal Representation
Attorney
Brian O'Donnell
USPTO Deadlines
Next Deadline
15 days remaining
Statement of Use Due - Extension 1 Granted
Due Date
August 20, 2025
Extension Available
Until August 20, 2025
Application History
22 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Mar 12, 2025 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
Mar 12, 2025 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
Mar 12, 2025 | EWAF | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | Loading... |
Mar 12, 2025 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
Mar 12, 2025 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
Mar 12, 2025 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
Feb 20, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Feb 20, 2025 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
Feb 19, 2025 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
Feb 19, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Aug 20, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
Jun 25, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
Jun 25, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Jun 5, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
May 18, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
May 17, 2024 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
May 17, 2024 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
May 17, 2024 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
May 17, 2024 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
May 9, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Apr 25, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Jan 5, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations, namely, a drug delivery system consisting of a multilayered tablet which can be tailored to individual patient needs by providing various functionalities, precision dosing of one or more APIs, and/or enhanced bioavailability for poorly soluble compounds through flexible compositions, unique designs, and different routes of oral administration routes
Class 040
Pharmaceutical manufacturing to the order and/or specification of others
Class 042
Development of pharmaceutical and nutraceutical preparations for others, namely, pharmaceutical and nutraceutical compounds in a multilayered tablet form for the rapid dispersion of a wide variety of therapeutic agents; research and development in the pharmaceutical and nutraceutical fields for others, namely, research and development of pharmaceutical and nutraceutical compounds in a multilayered tablet form for the rapid dispersion of a wide variety of therapeutic agents
Additional Information
Pseudo Mark
I TABLET
Classification
International Classes
005
040
042